ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report) shares traded up 0.8% during mid-day trading on Monday . The stock traded as high as C$6.70 and last traded at C$6.50. 19,980 shares changed hands during mid-day trading, an increase of 3% from the average session volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Stock Performance
The stock has a market capitalization of C$162.08 million and a price-to-earnings ratio of -7.30. The firm’s 50 day moving average is C$6.50 and its 200-day moving average is C$6.50. The company has a debt-to-equity ratio of 1.70, a quick ratio of 4.29 and a current ratio of 5.06.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
See Also
- Five stocks we like better than ImmunoPrecise Antibodies
- What is an Earnings Surprise?
- New Catalysts to Drive NVIDIA’s Stock Price Even Higher
- Investing in Construction Stocks
- China Market Movers: MCHI, PDD, BIDU Show Bullish Trends
- P/E Ratio Calculation: How to Assess Stocks
- Palantir Defies Bears, Leads S&P 500 in 2025
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
